Insomnia clinical trials

Explore recruiting insomnia clinical trials.

Recruiting insomnia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Insomnia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of low dose amitriptyline vs. cognitive behavioural therapy for chronic insomnia and medical comorbidity: a randomized controlled non inferiority trial.

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Efficacy of melatonin, low-dose quetiapine, or placebo in patients with psychiatric disorders and comorbid insomnia: a randomized clinical trial

Denmark

Phase II and Phase III (Integrated) EU CTIS Study details

Efficacy of melatonin, low-dose quetiapine, or placebo in adolescents with psychiatric disorders and comorbid insomnia: a randomized clinical trial

Denmark

Phase II and Phase III (Integrated) EU CTIS Study details

The CanISleepinMS Study: Effect of cannabidiol (CBD) on sleep quality in patients with multiple sclerosis, a series of 15 randomised, placebo-controlled N-of-1 trials

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A multi-center, double-blind, randomized, placebo-controlled, 2-way cross-over post approval study to investigate the efficacy of daridorexant in subjects with insomnia and comorbid nocturia

Spain, Germany

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy and Safety of Daridorexant in Patients with Major Depressive Disorder (MDD) and Insomnia: Double-blind, randomized, controlled trial

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Insomnia trials by city

Insomnia in Toronto Insomnia in Vancouver Insomnia in Montreal Insomnia in Calgary Insomnia in Edmonton Insomnia in Ottawa Insomnia in Winnipeg Insomnia in Quebec City Insomnia in Hamilton Insomnia in Kitchener Insomnia in London Insomnia in Halifax Insomnia in New York Insomnia in Los Angeles Insomnia in Chicago Insomnia in Houston

Other conditions

Huntington's disease Peripheral neuropathy Restless legs syndrome Essential tremor Dementia Depression Anxiety Bipolar disorder Schizophrenia PTSD OCD ADHD Postpartum depression Alcohol use disorder Substance use disorder COPD Asthma Long COVID Cystic fibrosis Pulmonary fibrosis Sleep apnea Chronic cough Crohn's disease Ulcerative colitis